Status:
COMPLETED
Clopidogrel Response in Acute Ischemic Stroke. The Bochumer CRISP Study
Lead Sponsor:
Ruhr University of Bochum
Conditions:
Ischemic Stroke
Eligibility:
All Genders
18+ years
Brief Summary
The aim of this study was to determine the prevalence rate and risk factors for chemical laboratory clopidogrel low-response (CLR) in the acute phase after an ischemic stroke.
Eligibility Criteria
Inclusion
- acute ischemic stroke
- admittance to stroke unit
- clopidogrel medication
Exclusion
- no consent
- prior bleeding disorders
- severe liver disorders
- current gastrointestinal disorders
- congestive heart failure
- life-threatening malignancies
Key Trial Info
Start Date :
July 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2012
Estimated Enrollment :
159 Patients enrolled
Trial Details
Trial ID
NCT01843361
Start Date
July 1 2010
End Date
December 1 2012
Last Update
April 30 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Neurology, Ruhr University Bochum
Bochum, Germany, 44791